TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $761,438 | -50.7% | 91,081 | +46.4% | 0.36% | -48.9% |
| Q2 2023 | $1,545,744 | +144.1% | 62,228 | +47.8% | 0.71% | +108.2% |
| Q1 2023 | $633,124 | +21.8% | 42,096 | -4.2% | 0.34% | +3.9% |
| Q4 2022 | $519,905 | +94.7% | 43,948 | -2.7% | 0.33% | +97.6% |
| Q3 2022 | $267,000 | +35.5% | 45,157 | -2.9% | 0.17% | +44.0% |
| Q2 2022 | $197,000 | -58.6% | 46,517 | -7.2% | 0.12% | -43.7% |
| Q1 2022 | $476,000 | -49.3% | 50,126 | +1.4% | 0.21% | -42.1% |
| Q4 2021 | $938,000 | – | 49,410 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |